Abstract
Cognitive decline in Parkinson’s disease (PD) is a common sequela of the disease, with its severity increasing as the neurodegenerative process advances. The present meta-analysis used anisotropic effect size seed-based d mapping software to perform analyses using both functional and structural brain imaging data. The analyses were between PD patients with mild cognitive impairment (PD-MCI) and PD patients with dementia (PDD) compared to PD cognitively unimpaired patients (PD-CU) and PD patients without dementia (PD-ND) respectively. Thirty-four studies were found and split into three analyses: 405 PD-MCI patients compared to 559 PD-CU patients from 1) 15 studies with structural imaging modalities and 2) eight studies with functional imaging modalities, as well as 178 PDD patients compared to 278 PD-ND patients (which includes both PD-CU and PD-MCI) in 3) 11 studies with structural imaging modalities. Statistical threshold was set to uncorrected p < 0.001. We found several brain regions that differed between PD-MCI and PD-CU patients: the left insula, bilateral dorsolateral prefrontal cortex, left angular gyrus, midcingulate cortex, and right supramarginal gyrus. The brain regions identified in the PD-MCI analyses are associated with the somatosensory network and executive processing. In PDD patients, the bilateral insula and right hippocampus were found as regions of structural atrophy. The insula was found in both structural analyses of PD-MCI and PDD, with unilateral insula involvement in PD-MCI extending to bilateral insula involvement in PDD. The results found both a spectrum of increasing brain atrophy in PD cognitive impairment and supports the existence of sub-typing in PD-MCI.
Similar content being viewed by others
References
Aarsland, D., Bronnick, K., Ehrt, U., De Deyn, P. P., Tekin, S., Emre, M., et al. (2007). Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: Frequency, profile and associated care giver stress. Journal of Neurology, Neurosurgery, and Psychiatry, 78(1), 36–42. https://doi.org/10.1136/jnnp.2005.083113.
Aarsland, D., Bronnick, K., & Fladby, T. (2011). Mild cognitive impairment in Parkinson's disease. Current Neurology and Neuroscience Reports, 11(4), 371–378. https://doi.org/10.1007/s11910-011-0203-1.
Alcaro, A., Huber, R., & Panksepp, J. (2007). Behavioral functions of the mesolimbic dopaminergic system: An affective neuroethological perspective. Brain Research Reviews, 56(2), 283–321.
Baggio, H. C., Segura, B., Sala-Llonch, R., Marti, M. J., Valldeoriola, F., Compta, Y., et al. (2015). Cognitive impairment and resting-state network connectivity in Parkinson's disease. Human Brain Mapping, 36(1), 199–212. https://doi.org/10.1002/hbm.22622.
Beyer, M. K., Janvin, C. C., Larsen, J. P., & Aarsland, D. (2007). A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. Journal of Neurology, Neurosurgery, and Psychiatry, 78(3), 254–259. https://doi.org/10.1136/jnnp.2006.093849.
Burton, E. J., McKeith, I. G., Burn, D. J., Williams, E. D., & O'Brien, J. T. (2004). Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain, 127(Pt 4), 791–800. https://doi.org/10.1093/brain/awh088.
Cauda, F., D'Agata, F., Sacco, K., Duca, S., Geminiani, G., & Vercelli, A. (2011). Functional connectivity of the insula in the resting brain. Neuroimage, 55(1), 8–23. https://doi.org/10.1016/j.neuroimage.2010.11.049.
Chang, L. J., Yarkoni, T., Khaw, M. W., & Sanfey, A. G. (2013). Decoding the role of the insula in human cognition: Functional parcellation and large-scale reverse inference. Cerebral Cortex, 23(3), 739–749. https://doi.org/10.1093/cercor/bhs065.
Chen, F. X., Kang, D. Z., Chen, F. Y., Liu, Y., Wu, G., Li, X., et al. (2016). Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease. Neuroscience Letters, 617, 160–165. https://doi.org/10.1016/j.neulet.2015.12.055.
Christopher, L., Koshimori, Y., Lang, A. E., Criaud, M., & Strafella, A. P. (2014). Uncovering the role of the insula in non-motor symptoms of Parkinson's disease. Brain, 137(Pt 8), 2143–2154, doi:https://doi.org/10.1093/brain/awu084.
Compta, Y., Ibarretxe-Bilbao, N., Pereira, J. B., Junque, C., Bargallo, N., Tolosa, E., et al. (2012). Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia. Parkinsonism & Related Disorders, 18(8), 941–947. https://doi.org/10.1016/j.parkreldis.2012.04.028.
Conte, A., Khan, N., Defazio, G., Rothwell, J. C., & Berardelli, A. (2013). Pathophysiology of somatosensory abnormalities in Parkinson disease. Nature Reviews. Neurology, 9(12), 687–697. https://doi.org/10.1038/nrneurol.2013.224.
Criaud, M., Christopher, L., Boulinguez, P., Ballanger, B., Lang, A. E., Cho, S. S., et al. (2016). Contribution of insula in Parkinson's disease: A quantitative meta-analysis study. Human Brain Mapping, 37(4), 1375–1392. https://doi.org/10.1002/hbm.23109.
Danti, S., Toschi, N., Diciotti, S., Tessa, C., Poletti, M., Del Dotto, P., et al. (2015). Cortical thickness in de novo patients with Parkinson disease and mild cognitive impairment with consideration of clinical phenotype and motor laterality. European Journal of Neurology, 22(12), 1564–1572. https://doi.org/10.1111/ene.12785.
Deen, B., Pitskel, N. B., & Pelphrey, K. A. (2011). Three systems of insular functional connectivity identified with cluster analysis. Cerebral Cortex, 21(7), 1498–1506. https://doi.org/10.1093/cercor/bhq186.
Duncan, G. W., Firbank, M. J., Yarnall, A. J., Khoo, T. K., Brooks, D. J., Barker, R. A., et al. (2016). Gray and white matter imaging: A biomarker for cognitive impairment in early Parkinson's disease? Movement Disorders, 31(1), 103–110. https://doi.org/10.1002/mds.26312.
Eichenbaum, H. (2000). A cortical-hippocampal system for declarative memory. Nature Reviews. Neuroscience, 1(1), 41–50. https://doi.org/10.1038/35036213.
Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., et al. (2007). Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders, 22(12), 1689–1707; quiz 1837, doi:https://doi.org/10.1002/mds.21507.
Etter, G., & Krezel, W. (2014). Dopamine D2 receptor controls hilar mossy cells excitability. Hippocampus, 24(7), 725–732. https://doi.org/10.1002/hipo.22280.
Frost, J. A., Binder, J. R., Springer, J. A., Hammeke, T. A., Bellgowan, P. S. F., Rao, S. M., et al. (1999). Language processing is strongly left lateralized in both sexes - evidence from functional MRI. Brain, 122, 199–208. https://doi.org/10.1093/brain/122.2.199.
Garcia-Garcia, D., Clavero, P., Gasca Salas, C., Lamet, I., Arbizu, J., Gonzalez-Redondo, R., et al. (2012). Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. European Journal of Nuclear Medicine and Molecular Imaging, 39(11), 1767–1777. https://doi.org/10.1007/s00259-012-2198-5.
Gee, M., Dukart, J., Draganski, B., Wayne Martin, W. R., Emery, D., & Camicioli, R. (2017). Regional volumetric change in Parkinson's disease with cognitive decline. Journal of the Neurological Sciences, 373, 88–94. https://doi.org/10.1016/j.jns.2016.12.030.
Goldman, J. G., Stebbins, G. T., Dinh, V., Bernard, B., Merkitch, D., de Toledo-Morrell, L., et al. (2014). Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations. Brain, 137(Pt 3), 849–859, doi:https://doi.org/10.1093/brain/awt360.
Gomperts, S. N., Locascio, J. J., Rentz, D., Santarlasci, A., Marquie, M., Johnson, K. A., et al. (2013). Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia. Neurology, 80(1), 85–91. https://doi.org/10.1212/WNL.0b013e31827b1a07.
Gonzalez-Redondo, R., Garcia-Garcia, D., Clavero, P., Gasca-Salas, C., Garcia-Eulate, R., Zubieta, J. L., et al. (2014). Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: A two-step process. Brain, 137(Pt 8), 2356–2367, doi:https://doi.org/10.1093/brain/awu159.
Gratwicke, J., Jahanshahi, M., & Foltynie, T. (2015). Parkinson's disease dementia: A neural networks perspective. Brain, 138(Pt 6), 1454–1476, doi:https://doi.org/10.1093/brain/awv104.
Hanganu, A., Bedetti, C., Jubault, T., Gagnon, J. F., Mejia-Constain, B., Degroot, C., et al. (2013). Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration. Movement Disorders, 28(10), 1360–1369. https://doi.org/10.1002/mds.25541.
Hanganu, A., Bedetti, C., Degroot, C., Mejia-Constain, B., Lafontaine, A. L., Soland, V., et al. (2014). Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally. Brain, 137(Pt 4), 1120–1129, doi:https://doi.org/10.1093/brain/awu036.
Hosokai, Y., Nishio, Y., Hirayama, K., Takeda, A., Ishioka, T., Sawada, Y., et al. (2009). Distinct patterns of regional cerebral glucose metabolism in Parkinson's disease with and without mild cognitive impairment. Movement Disorders, 24(6), 854–862. https://doi.org/10.1002/mds.22444.
Hou, Y., Yang, J., Luo, C., Song, W., Ou, R., Liu, W., et al. (2016). Dysfunction of the default mode network in drug-naive Parkinson's disease with mild cognitive impairments: A resting-state fMRI study. Frontiers in Aging Neuroscience, 8, 247. https://doi.org/10.3389/fnagi.2016.00247.
Huang, C., Mattis, P., Perrine, K., Brown, N., Dhawan, V., & Eidelberg, D. (2008). Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology, 70(16 Pt 2), 1470–1477, doi:https://doi.org/10.1212/01.wnl.0000304050.05332.9c.
Hutton, C., Draganski, B., Ashburner, J., & Weiskopf, N. (2009). A comparison between voxel-based cortical thickness and voxel-based morphometry in normal aging. Neuroimage, 48(2), 371–380. https://doi.org/10.1016/j.neuroimage.2009.06.043.
Ibarretxe-Bilbao, N., Ramirez-Ruiz, B., Tolosa, E., Marti, M. J., Valldeoriola, F., Bargallo, N., et al. (2008). Hippocampal head atrophy predominance in Parkinson's disease with hallucinations and with dementia. Journal of Neurology, 255(9), 1324–1331. https://doi.org/10.1007/s00415-008-0885-8.
Janvin, C. C., Larsen, J. P., Aarsland, D., & Hugdahl, K. (2006). Subtypes of mild cognitive impairment in Parkinson's disease: Progression to dementia. Movement Disorders, 21(9), 1343–1349. https://doi.org/10.1002/mds.20974.
Kalbe, E., Rehberg, S. P., Heber, I., Kronenbuerger, M., Schulz, J. B., Storch, A., et al. (2016). Subtypes of mild cognitive impairment in patients with Parkinson's disease: Evidence from the LANDSCAPE study. Journal of Neurology, Neurosurgery, and Psychiatry, 87(10), 1099–1105. https://doi.org/10.1136/jnnp-2016-313838.
Kehagia, A. A., Barker, R. A., & Robbins, T. W. (2010). Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurology, 9(12), 1200–1213. https://doi.org/10.1016/S1474-4422(10)70212-X.
Klein, T. A., Ullsperger, M., & Danielmeier, C. (2013). Error awareness and the insula: Links to neurological and psychiatric diseases. Frontiers in Human Neuroscience, 7, 14. https://doi.org/10.3389/fnhum.2013.00014.
Koller, W. C. (1984). Sensory symptoms in Parkinson's disease. Neurology, 34(7), 957–959.
La Fougere, C., Zwergal, A., Rominger, A., Förster, S., Fesl, G., Dieterich, M., et al. (2010). Real versus imagined locomotion: A [18 F]-FDG PET-fMRI comparison. Neuroimage, 50(4), 1589–1598.
Laird, A. R., Fox, P. M., Price, C. J., Glahn, D. C., Uecker, A. M., Lancaster, J. L., et al. (2005). ALE meta-analysis: Controlling the false discovery rate and performing statistical contrasts. Human Brain Mapping, 25(1), 155–164. https://doi.org/10.1002/hbm.20136.
Lancaster, J. L., Tordesillas-Gutierrez, D., Martinez, M., Salinas, F., Evans, A., Zilles, K., et al. (2007). Bias between MNI and Talairach coordinates analyzed using the ICBM-152 brain template. Human Brain Mapping, 28(11), 1194–1205. https://doi.org/10.1002/hbm.20345.
Lara, A. H., & Wallis, J. D. (2015). The role of prefrontal cortex in working memory: A mini review. Frontiers in Systems Neuroscience, 9, 173. https://doi.org/10.3389/fnsys.2015.00173.
Lee, S. H., Kim, S. S., Tae, W. S., Lee, S. Y., Lee, K. U., & Jhoo, J. (2013). Brain volumetry in Parkinson's disease with and without dementia: Where are the differences? Acta Radiologica, 54(5), 581–586. https://doi.org/10.1177/0284185113476029.
Litvan, I., Goldman, J. G., Troster, A. I., Schmand, B. A., Weintraub, D., Petersen, R. C., et al. (2012). Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society task force guidelines. Movement Disorders, 27(3), 349–356. https://doi.org/10.1002/mds.24893.
Lyoo, C. H., Jeong, Y., Ryu, Y. H., Rinne, J. O., & Lee, M. S. (2010). Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment. European Neurology, 64(2), 65–73. https://doi.org/10.1159/000315036.
Mak, E., Su, L., Williams, G. B., & O'Brien, J. T. (2014a). Neuroimaging characteristics of dementia with Lewy bodies. Alzheimer's Research & Therapy, 6(2), 18. https://doi.org/10.1186/alzrt248.
Mak, E., Zhou, J., Tan, L. C., Au, W. L., Sitoh, Y. Y., & Kandiah, N. (2014b). Cognitive deficits in mild Parkinson's disease are associated with distinct areas of grey matter atrophy. Journal of Neurology, Neurosurgery, and Psychiatry, 85(5), 576–580. https://doi.org/10.1136/jnnp-2013-305805.
Mak, E., Su, L., Williams, G. B., Firbank, M. J., Lawson, R. A., Yarnall, A. J., et al. (2015). Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease: ICICLE-PD study. Brain, 138(Pt 10), 2974–2986, doi:https://doi.org/10.1093/brain/awv211.
Masdeu, J., Eisenberg, D., Hegarty, C., Cropp, B., Rubinstein, D., Kohn, P., et al. (2014). Dorsolateral prefrontal cortex modulation by caudate dopamine during a working memory task in Parkinson disease (P6. 317). Neurology, 82(10 Supplement), P6. 317.
McKeith, I. G., Galasko, D., Kosaka, K., Perry, E. K., Dickson, D. W., Hansen, L. A., et al. (1996). Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology, 47(5), 1113–1124.
Melzer, T. R., Watts, R., MacAskill, M. R., Pitcher, T. L., Livingston, L., Keenan, R. J., et al. (2012). Grey matter atrophy in cognitively impaired Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 83(2), 188–194. https://doi.org/10.1136/jnnp-2011-300828.
Miller, E. K., & Cohen, J. D. (2001). An integrative theory of prefrontal cortex function. Annual Review of Neuroscience, 24(1), 167–202.
Monchi, O., Petrides, M., Mejia-Constain, B., Strafella, A. P. (2006). Cortical activity in Parkinson’s disease during executive processing depends on striatal involvement. Brain, 130(1), 233–244.
Nagano-Saito, A., Washimi, Y., Arahata, Y., Kachi, T., Lerch, J. P., Evans, A. C., et al. (2005). Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology, 64(2), 224–229. https://doi.org/10.1212/01.WNL.0000149510.41793.50.
Nakao, T., Radua, J., Rubia, K., & Mataix-Cols, D. (2011). Gray matter volume abnormalities in ADHD: Voxel-based meta-analysis exploring the effects of age and stimulant medication. The American Journal of Psychiatry, 168(11), 1154–1163. https://doi.org/10.1176/appi.ajp.2011.11020281.
Noh, S. W., Han, Y. H., Mun, C. W., Chung, E. J., Kim, E. G., Ji, K. H., et al. (2014). Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment. Journal of the Neurological Sciences, 347(1–2), 210–213. https://doi.org/10.1016/j.jns.2014.09.049.
Nyberg, L., Karalija, N., Salami, A., Andersson, M., Wahlin, A., Kaboovand, N., et al. (2016). Dopamine D2 receptor availability is linked to hippocampal-caudate functional connectivity and episodic memory. Proceedings of the National Academy of Sciences of the United States of America, 113(28), 7918–7923. https://doi.org/10.1073/pnas.1606309113.
Okada, A., Nakamura, T., Suzuki, J., Suzuki, M., Hirayama, M., Katsuno, M., et al. (2016). Impaired pain processing correlates with cognitive impairment in Parkinson's disease. Internal Medicine, 55(21), 3113–3118. https://doi.org/10.2169/internalmedicine.55.7067.
Pagonabarraga, J., Corcuera-Solano, I., Vives-Gilabert, Y., Llebaria, G., Garcia-Sanchez, C., Pascual-Sedano, B., et al. (2013). Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease. PLoS One, 8(1), e54980. https://doi.org/10.1371/journal.pone.0054980.
Pan, P. L., Shi, H. C., Zhong, J. G., Xiao, P. R., Shen, Y., Wu, L. J., et al. (2013). Gray matter atrophy in Parkinson's disease with dementia: Evidence from meta-analysis of voxel-based morphometry studies. Neurological Sciences, 34(5), 613–619. https://doi.org/10.1007/s10072-012-1250-3.
Peraza, L. R., Nesbitt, D., Lawson, R. A., Duncan, G. W., Yarnall, A. J., Khoo, T. K., et al. (2017). Intra- and inter-network functional alterations in Parkinson’s disease with mild cognitive impairment. Human Brain Mapping, 38(3), 1702–1715.
Pereira, J. B., Svenningsson, P., Weintraub, D., Bronnick, K., Lebedev, A., Westman, E., et al. (2014). Initial cognitive decline is associated with cortical thinning in early Parkinson disease. Neurology, 82(22), 2017–2025. https://doi.org/10.1212/WNL.0000000000000483.
Radua, J., & Mataix-Cols, D. (2009). Voxel-wise meta-analysis of grey matter changes in obsessive–compulsive disorder. The British Journal of Psychiatry, 195(5), 393–402.
Radua, J., van den Heuvel, O. A., Surguladze, S., & Mataix-Cols, D. (2010). Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Archives of General Psychiatry, 67(7), 701–711, doi:https://doi.org/10.1001/archgenpsychiatry.2010.70.
Radua, J., Mataix-Cols, D., Phillips, M. L., El-Hage, W., Kronhaus, D. M., Cardoner, N., et al. (2012). A new meta-analytic method for neuroimaging studies that combines reported peak coordinates and statistical parametric maps. European Psychiatry, 27(8), 605–611. https://doi.org/10.1016/j.eurpsy.2011.04.001.
Riedl, V., Bienkowska, K., Strobel, C., Tahmasian, M., Grimmer, T., Forster, S., et al. (2014). Local activity determines functional connectivity in the resting human brain: A simultaneous FDG-PET/fMRI study. The Journal of Neuroscience, 34(18), 6260–6266. https://doi.org/10.1523/JNEUROSCI.0492-14.2014.
Rocchetti, J., Isingrini, E., Dal Bo, G., Sagheby, S., Menegaux, A., Tronche, F., et al. (2015). Presynaptic D2 dopamine receptors control long-term depression expression and memory processes in the temporal hippocampus. Biological Psychiatry, 77(6), 513–525. https://doi.org/10.1016/j.biopsych.2014.03.013.
Seghier, M. L. (2013). The angular gyrus: Multiple functions and multiple subdivisions. Neuroscientist, 19(1), 43–61. https://doi.org/10.1177/1073858412440596.
Segura, B., Baggio, H. C., Marti, M. J., Valldeoriola, F., Compta, Y., Garcia-Diaz, A. I., et al. (2014). Cortical thinning associated with mild cognitive impairment in Parkinson's disease. Movement Disorders, 29(12), 1495–1503. https://doi.org/10.1002/mds.25982.
Song, S. K., Lee, J. E., Park, H. J., Sohn, Y. H., Lee, J. D., & Lee, P. H. (2011). The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Movement Disorders, 26(2), 289–296. https://doi.org/10.1002/mds.23477.
Su, Q., Yao, D., Jiang, M., Liu, F., Long, L., Dai, Y., et al. (2016). Decreased interhemispheric functional connectivity in insula and angular gyrus/supramarginal gyrus: Significant findings in first-episode, drug-naive somatization disorder. Psychiatry Research, 248, 48–54. https://doi.org/10.1016/j.pscychresns.2016.01.008.
Summerfield, C., Junque, C., Tolosa, E., Salgado-Pineda, P., Gomez-Anson, B., Marti, M. J., et al. (2005). Structural brain changes in Parkinson disease with dementia: A voxel-based morphometry study. Archives of Neurology, 62(2), 281–285. https://doi.org/10.1001/archneur.62.2.281.
Tang, Y., Ge, J., Liu, F., Wu, P., Guo, S., Liu, Z., et al. (2016). Cerebral metabolic differences associated with cognitive impairment in Parkinson's disease. PLoS One, 11(4), e0152716. https://doi.org/10.1371/journal.pone.0152716.
Taylor, K. S., Seminowicz, D. A., & Davis, K. D. (2009). Two Systems of Resting State Connectivity between the insula and cingulate cortex. Human Brain Mapping, 30(9), 2731–2745. https://doi.org/10.1002/hbm.20705.
Vogt, B. A. (2016). Midcingulate cortex: Structure, connections, homologies, functions and diseases. Journal of Chemical Neuroanatomy, 74, 28–46. https://doi.org/10.1016/j.jchemneu.2016.01.010.
Wagner, A. D., Maril, A., Bjork, R. A., & Schacter, D. L. (2001). Prefrontal contributions to executive control: fMRI evidence for functional distinctions within lateral prefrontal cortex. Neuroimage, 14(6), 1337–1347.
Williams-Gray, C. H., Foltynie, T., Brayne, C. E., Robbins, T. W., & Barker, R. A. (2007). Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain, 130(Pt 7), 1787–1798. https://doi.org/10.1093/brain/awm111.
Williams-Gray, C. H., Evans, J. R., Goris, A., Foltynie, T., Ban, M., Robbins, T. W., et al. (2009). The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain, 132(Pt 11), 2958–2969, doi:https://doi.org/10.1093/brain/awp245.
Wise, T., Radua, J., Nortje, G., Cleare, A. J., Young, A. H., & Arnone, D. (2016). Voxel-based meta-analytical evidence of structural Disconnectivity in major depression and bipolar disorder. Biological Psychiatry, 79(4), 293–302. https://doi.org/10.1016/j.biopsych.2015.03.004.
Xia, J., Miu, J., Ding, H., Wang, X., Chen, H., Wang, J., et al. (2013). Changes of brain gray matter structure in Parkinson's disease patients with dementia. Neural Regeneration Research, 8(14), 1276–1285. https://doi.org/10.3969/j.issn.1673-5374.2013.14.004.
Xu, Y., Yang, J., Hu, X., & Shang, H. (2016). Voxel-based meta-analysis of gray matter volume reductions associated with cognitive impairment in Parkinson's disease. Journal of Neurology, 263(6), 1178–1187. https://doi.org/10.1007/s00415-016-8122-3.
Zarei, M., Ibarretxe-Bilbao, N., Compta, Y., Hough, M., Junque, C., Bargallo, N., et al. (2013). Cortical thinning is associated with disease stages and dementia in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry, 84(8), 875–882. https://doi.org/10.1136/jnnp-2012-304126.
Zhang, J., Zhang, Y. T., Hu, W. D., Li, L., Liu, G. Y., & Bai, Y. P. (2015). Gray matter atrophy in patients with Parkinson's disease and those with mild cognitive impairment: A voxel-based morphometry study. International Journal of Clinical and Experimental Medicine, 8(9), 15383–15392.
Acknowledgements
We would like to thank all authors of the studies included in the meta-analysis for use their data and coordinates.
Funding
This study was funded by Canadian Institutes of Health Research (MOP 136778). A.P.S. is supported by the Canada Research Chair program.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare they have no conflict of interest with this study.
Ethical approval
This article does not contain any studies with human participants performed by any of the authors.
Electronic supplementary material
ESM 1
(DOCX 46 kb)
Rights and permissions
About this article
Cite this article
Mihaescu, A.S., Masellis, M., Graff-Guerrero, A. et al. Brain degeneration in Parkinson’s disease patients with cognitive decline: a coordinate-based meta-analysis. Brain Imaging and Behavior 13, 1021–1034 (2019). https://doi.org/10.1007/s11682-018-9922-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11682-018-9922-0